SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
夏睿阳
Lv2
120 积分
2023-07-03 加入
最近求助
最近应助
互助留言
Disitamab vedotin alone or in combination with immune checkpoint inhibitors in bladder-sparing treatment of muscle-invasive bladder cancer: a real-world study
7天前
已完结
Bladder cancer
11天前
已完结
Clinicopathologic features and treatment advances in cancers with HER2 alterations
12天前
已完结
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer
13天前
已完结
Sarcopenia Affects Liver Regeneration and Long-Term Survival Rate After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma
23天前
已完结
Immunotherapy as a Downstaging Therapy for Liver Transplantation
1个月前
已完结
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors
1个月前
已完结
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
1个月前
已完结
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
1个月前
已完结
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives
2个月前
已完结
没有进行任何应助
看错了看错了
13天前
文章不对
13天前
感谢,点赞,速度真快,么么哒,帮大忙了
2个月前
感谢,非常感谢 太快了,么么哒
3个月前
感谢,速度真快,帮大忙了,么么哒
5个月前
感谢,点赞,速度真快,帮大忙了,么么哒
5个月前
感谢,点赞,速度真快,帮大忙了,么么哒
8个月前
感谢,点赞,速度真快,帮大忙了,么么哒
8个月前
感谢,点赞,速度真快,帮大忙了,么么哒
8个月前
感谢,点赞,速度真快,帮大忙了,么么哒
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论